Study to Evaluate Efficacy and Safety of DR-102 for the Prevention of Pregnancy

Study Title
A Study to Evaluate the Efficacy and Safety of DR-102 for the Prevention of Pregnancy
Teva Identifier
DSG-PPS-303
ClinicalTrials.gov Identifier
NCT01178125
Study Status
Completed
Trial Condition(s)
Contraception | Female Contraception
Interventions
Drug: DR-102

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Print

Participation criteria and map of study locations


Key Participation Requirements

Gender
Female
Age group
Adult
Age Range
18 Years to 40 Years
Trial Duration
08/01/2010 - 01/01/2013
Phase
Phase 3

Study Type

Interventional